incorporating novel therapies into frontline all treatment
Published 6 years ago • 58 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:50
the value of moving novel agents into the frontline setting in all
-
1:15
bringing novel agents to the frontline setting in myeloma
-
0:57
novel therapeutic strategies in all
-
3:40
how the aml treatment landscape has evolved with the use of novel combination therapies
-
1:33
addressing the potential role of immunotherapy in the frontline treatment of all
-
1:42
novel treatment combinations in aml: what’s to come?
-
0:49
exploring novel treatment strategies for ph-like all
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
6:25
novel tools to monitor the immune system in lymphoma clinical trials
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
3:13
which cancers can be treated with immunotherapy? ask a scientist
-
1:11
exciting updates in all and the value of novel immunotherapies
-
1:27
novel agents or imatinib for cml in the frontline setting?
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
1:32
novel treatment combinations for flt3-mutated aml
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:12
novel treatment strategies for richter’s transformation
-
5:47
novel therapeutic approaches in b-progenitor all
-
3:51
the role of frontline chemoimmunotherapy in the era of novel agents in cll
-
2:34
the evolution of the aml treatment paradigm
-
2:25
analyzing aml: novel therapies in review